Vitronectin binding to urokinase receptor in human breast cancer

Clinical Cancer Research

Volumn 3, Issue 8, 1997, Pages 1299-1308

  Carriero, Maria V ^a   Del Vecchio, Silvana ^b   Franco, Paola ^a   Potena, Maria I ^a   Chiaradonna, Ferdinando ^c   Botti, Gerardo ^a   Stoppelli, M Patrizia ^c   Salvatore, Marco ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125; RECEPTOR; UROKINASE; VITRONECTIN;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; COMPLEX FORMATION; CROSS LINKING; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

ANIMALS; BREAST NEOPLASMS; CELL ADHESION; FEMALE; HUMANS; KINETICS; L CELLS (CELL LINE); MICE; PEPTIDE FRAGMENTS; PROTEIN DENATURATION; RECEPTORS, CELL SURFACE; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; RECOMBINANT PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; VITRONECTIN;

EID: 0030811592     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Vassalli, J. D. The Urokinase Receptor. Fibrinolysis, 8: 172-181, 1994.
2. Hynes, R. O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell, 69: 11-25, 1992.
3. Dano, K., Behrendt, N., Brunner, N., Ellis, V., Ploug, M., and Pyke, C. The urokinase receptor: protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis, 8: 189-203, 1994.
4. Pepper, M. S., Vassalli, J. D., Montesano, R., and Orci, L. Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells. J. Cell Biol., 105: 2535-2541, 1987.
5. Strickland, S., Reich, E., and Scherman, M. I. Plasminogen activator in early embryogenesis: enzyme production by trophoblast and parietal endoderm. Cell, 15: 393-403, 1976.
6. Blasi, F., Vassalli, J. D., and Dano, K. Urokinase-type plasminogen activator: pro-enzyme, receptor, and inhibitors. J. Cell Biol., 104: 801-804, 1987.
7. Camiolo, S. M., Markus, G., and Evers, J. L. Plasminogen activator content of neoplastic and benign human prostate tissues: fibrin augmentation of an activator activity. Int. J. Cancer, 27: 191-198, 1981.
8. Grondahl-Hansen, J., Christensen, I. J., Rosenquist, C., Brunner, N., Mouridsen, H. T., Dano, K., and Blichert-Toft, M. High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res., 53: 2513-2521, 1993.
9. r 55,000 form of the human plasminogen activator urokinase. J. Cell Biol., 100: 86-92, 1985.
10. Stoppelli, M. P., Corti, A., Soffientini, A., Cassani, G., Blasi, F., and Assoian, R. K. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc. Natl. Acad. Sci. USA, 82: 4939-4943, 1985.
11. Ellis, V., Behrendt, N., and Dano, K. Plasminogen activation by receptor-bound urokinase. J. Biol. Chem., 266: 12752-12758, 1991.
12. Stoppelli, M. P., Tacchetti, C., Cubellis, M. V., Corti, A., Hearing, V. J., Cassani, G., Appella, E., and Blasi, F. Autocrine saturation of pro-urokinase receptors on human A431 cells. Cell, 45: 675-684, 1986.
13. Kook, Y. H., Adamski, J., Zelent, A., and Ossowski, L. The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy. EMBO J., 13: 3983-3991, 1994.
14. Pyke, C., Graem, N., Ralfkiaer, E., Ronne, E., Hoyer-Hansen, G., Brunner, N., and Dano, K. Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. Cancer Res., 53: 1911-1915, 1993.
15. Bianchi, E., Cohen, R. L., Thor, A. T., Todd, R. F., III, Mizukami, I. F., Lawrence, D. A., Ljung, B. M., Shuman, M. A., and Smith, H. S. The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res., 54: 861-866, 1994.
16. Foekens, J. A., Schmitt, M., Van Putten, W. L. J., Peters, H. A., Bontenbal, M., Janicke, F., and Klijn, J. G. M. Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients. Cancer Res., 52: 6101-6105, 1992.
17. Ronne, E., Hayer-Hansen, G., Brunner, N., Pedersen, H., Rank, F., Osborne, C. K., Clark, G. M., Dano, K., and Grondahl-Hansen, J. Urokinase receptor in breast tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono-and polyclonal antibodies. Breast Cancer Res. Treat., 33: 199-207, 1995.
18. Pedersen, H., Brumer, N., Francis, D., Osterlind, K., Ronne, E., Hansen, H. H., Dano, K., and Grondahl-Hansen, J. Prognostic impact of urokinase, urokinase receptor and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue. Cancer Res., 54: 4671-4675, 1994.
19. r receptor protein for urokinase-type-plasminogen activator. J. Biol. Chem., 263: 2358-2363, 1988.
20. Myohanen, H. T., Stephens, R. W., Hedman, K., Tapiovaara, H., Ronne, E., Hoier-Hansen, G., Dano, K., and Vaheri, A. Distribution and lateral mobility of the urokinase-receptor complex at the cell surface. J. Histochem. Cytochem., 41: 1291-1301, 1993.
21. 138/303 impairs its receptor-dependent ability to promote myelomonocytic adherence and motility. J. Cell Biol., 137: 779-790, 1997.
22. Waltz, D. A., Sailor, L. Z., and Chapman, H. A. Cytokines induce urokinase-dependent adhesion of human myeloid cells. J. Clin. Invest., 91: 1541-1552, 1993.
23. Wei, Y., Waltz, D. A., Rao, N., Drummond, R. J., Rosemberg, S., and Chapman, H. A. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem., 269: 32380-32388, 1994.
24. Moser, T. L., Enghild, J. J., Pizzo, S. V., and Stack, M. S. Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells. Biochem. J., 307: 867-873, 1995.
25. Tomasini, B. R., and Mosher, D. F. Conformational states of vitronectin: preferential expression of an antigenic epitope when vitronectin is covalently and noncovalently complexed with thrombin-antithrombin III or treated with urea. Blood, 72: 903-912, 1988.
26. x) is responsible for distinct adhesive properties of carcinoma cells. Cell, 57: 59-69, 1989.
27. Zutter, M. M., Mazoujian, G., and Santoro, S. A. Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast. Am. J. Pathol., 137: 863-870, 1990.
28. Pollanen, J., Hedman, K., Nielsen, L. S., and Vaheri, A. Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts. J. Cell Biol., 106: 87-95, 1988.
29. Ciambrone, G. J, and Mc Keown-Longo, P. Vitronectin regulates the synthesis and localization of urokinase-type plasminogen activator in HT1080 Cells. J. Biol. Chem., 267; 13617-13622, 1992.
30. Salonen, E. M., Vaheri, A., Pollanen, J., Stephens, R., Andreasen, P., Mayer, M., Dano, K., Gailit, J., and Ruoslahti, E. Interaction of plasminogen activator inhibitor (PAI-1) with vitronectin. J. Biol. Chem., 264: 6339-6343, 1989.
31. 3 binding to vitronectin. Nature (Lond.), 383: 441-443, 1996.
32. Waltz, D. A., and Chapman, H. A. Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J. Biol. Chem., 269: 14746-14750, 1994.
33. Carriero, M. V., Franco, P., Del Vecchio, S., Massa, O., Botti, G., D'Aiuto, G., Stoppelli, M. P., and Salvatore, M. Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies. Cancer Res., 54: 5445-5454, 1994.
34. Nolli, M. L., Corti, A., Soffientini, A., and Cassani, G. A monoclonal antibody that recognizes the receptor binding region of human urokinase-type plasminogen activator. Thromb. Haemostasis, 56: 214-218, 1986.
35. Roldan, A., Cubellis, M. V., Masucci, M. T., Behrendt, N., Lund, L. R., Dano, K., Appella, E., and Blasi, F. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J., 9: 467-474, 1990.
36. Tortora, G., Pepe, S., Bianco, C., Baldassarre, G., Budillon, A., Clair, T., Cho-Chung, Y. S., Bianco, R., and Ciardiello, F. The RIα subunit of protein kinase A controls serum dependency and entry into cell cycle of human mammary epithelial cells. Oncogene, 9: 3233-3240, 1994.
37. Del Vecchio, S., Stoppelli, M. P., Carriero, M. V., Fonti, R., Massa, O., Li, P. Y., Botti, G., Cerra, M., D'Aiuto, G., Esposito, G., and Salvatore, M. Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels. Cancer Res., 53: 3198-3206, 1993.
38. Bittorf, S. V., Williams, E. C., Mosher, D. F. Alteration of vitronectin. J. Biol. Chem., 268: 24838-24846, 1993.
39. 2-macroglobulin receptor in human breast carcinomas. Int. J. Cancer, 66: 441-452, 1996.
40. Kohn, E. C., and Liotta, L. A. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res., 55: 1856-1862, 1995.
41. Cajot, J. F., Schleuning, W. D., Medcalf, R. L., Bamat, J., Testuz, J., Lieberman, L., and Sordat, B. Mouse L cells expressing pro-urokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion. J. Cell Biol., 109: 915-925, 1989.
42. Betsholtz, C., Westermark, Ek,. B., and Heldin, C. H. Coexpression of a PDGF-like growth factor and PDGF receptors in a human osteosarcoma cell line: implications for autocrine receptor activation. Cell, 39: 447-457, 1984.
43. Coffey, R. J., Goustin, A. S., Soderquist, A. M., Shipley, G. D., Wolfshohl, J., Carpenter, G., and Moses, H. L. Transforming growth factor α and β expression in human colon cancer lines: implications for an autocrine model. Cancer Res., 47: 4590-4594, 1987.
44. 125I-galanin binding in rat brain: relationship with the rate of occupancy of galanin receptors by endogeneous galanin. Neuroscience, 49: 829-847, 1992.
45. Zutter, M. M., Krigman, H. R., and Santoro, S. A. Altered integrin expression in adenocarcinoma of the breast. Am. J. Pathol., 142: 1439-1448, 1993.
46. Glukhova, M., Koteliansky, V., Sastre, X., and Thiery, J. P. Adhesion system in normal breast and in invasive carcinoma. Am. J. Pathol., 146: 706-716, 1995.
47. Busso, N., Masur, S. K., Lazega, D., Waxman, S., and Ossowski, L. Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. J. Cell Biol., 126: 259-270, 1994.